GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (FRA:BIO) » Definitions » Net Interest Income

Biotest AG (FRA:BIO) Net Interest Income : €-38.4 Mil (TTM As of Jun. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Biotest AG's net interest income for the three months ended in Jun. 2024 was €-8.3 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2024 was €-38.4 Mil.

Biotest AG Net Interest Income Historical Data

The historical data trend for Biotest AG's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Net Interest Income Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.70 -15.80 -15.70 -22.80 -38.20

Biotest AG Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.30 -10.60 -8.80 -10.70 -8.30

Biotest AG Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-38.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest AG Net Interest Income Related Terms

Thank you for viewing the detailed overview of Biotest AG's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (FRA:BIO) » Definitions » Net Interest Income
Comparable Companies
XTER:FYB XTER:HPHA XTER:MDG1 FRA:D89 FRA:T5O0 OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX BGNE BNTX OCSE:GMAB BMRN UTHR
Traded in Other Exchanges
BIO3:Germany BIO3:Austria
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Website
https://www.biotest.com
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.